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PRELIMINARY COMMUNICATION
WHO International Pilot Study of Schizophrenia1
N. SARTORIUS, R. SHAPIRO, M. KIMURA, and K. BARRETT
From the WHO Mental Health Unit, Geneva
SYNOPSIS The results are described of a transcultural psychiatric study of schizophrenia undertaken
by WHO in nine countries. The study proved that such a collaboration was feasible, that it was
possible to develop research procedures for international use, and that similar types of schizophrenia
could be found in each of the countries involved. One thousand two hundred and two patients were
studied and over 2 million items of information obtained.
Approximately one person out of every 100 will
become ill with schizophrenia at some time dur-
ing his life. In some countries, as many as one
quarter of all hospital beds are occupied by
individuals diagnosed as schizophrenic. As
schizophrenia is so often a chronic, disabling
condition, it is clear that among the diseases,
physical and mental, which afflict mankind,
schizophrenia is one of the major causes of
suffering and loss of productivity. This was one
This project is sponsored by the World Health Organization,
and funded by the World Health Organization, the National
Institute of Mental Health (United States of America) and
the participating field research centres.
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of the main reasons that schizophrenia was
selected as the subject of a major transcultural
psychiatric study undertaken by the World
Health Organization—the International Pilot
Study of Schizophrenia (IPSS).
Although the importance of basic epidemiolo-
gical studies in the understanding of diseases is
now well established in the general field of
medicine, certain problems have made it
difficult to carry out such basic studies within the
field of psychiatry. The lack of universally
acceptable definitions of specific syndromes and
diseases has made the identification of a case
even more of a problem in psychiatry than in
other branches of medicine. Standardized re-
search instruments and procedures that would be
applicable in many different cultural and social
settings have also been lacking. The question of
whether psychiatrists from widely separated
countries with different cultural and socio-
economic conditions can collaborate effectively
on a major scale has not been definitively
answered.
The International Pilot Study of Schizophrenia
was designed to investigate the feasibility of such
collaboration, to develop standardized instru-
ments and procedures for a reliable evaluation in
different countries of the clinical conditions of
patients suffering from psychiatric illness, parti-
cularly schizophrenia, and to determine whether
groups of schizophrenic patients with similar
characteristics could be identified in many
different countries and cultures.
This study is part of the World Health
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Organization's long-term plan in psychiatric
epidemiology and social psychiatry. The plan
consists of four interlinked programmes. Pro-
gramme A is concerned with the standardization
of psychiatric diagnosis, classification, and
statistics. Programme B is concerned with the
development of internationally applicable tech-
niques for the evaluation of mental patients in
epidemiological and other psychiatric studies.
Programmes A and B are preparatory for
Programme C, which consists of comprehensive
epidemiological studies of psychiatric disorders
in geographically defined populations. The fourth
part, Programme D, is an international research
training programme in psychiatric epidemiology
and social psychiatry designed to help meet the
urgent manpower needs in this field. The IPSS
is the major vehicle of Programme B.
Field research centres for the study were
selected in nine countries: Colombia (University
del Valle, Cali); Czechoslovakia (Psychiatric
Research Institute, Prague); Denmark (Univer-
sity of Aarhus, Risskov); India (Mental Hospital,
Agra); Nigeria (University College Hospital,
Ibadan); Republic of China (Taiwan University
Hospital, Taipei, Taiwan); Union of Soviet
Socialist Republics (Institute of Psychiatry of the
USSR Academy of Medical Sciences, Moscow);
United Kingdom (Medical Research Council
Social Psychiatry Research Unit, London); and
the United States of America (National Institute
of Mental Health, Maryland). Field research
centre teams were composed of a principal
collaborating investigator, other psychiatrists,
psychologists, social workers, and statisticians.
In each field research centre, team members were
all from the country concerned.2 Over 1,200
patients were included in the study.
Three major conclusions stand out from the
IPSS experience to date. The first is that it has
been possible to carry out a large-scale inter-
national psychiatric study requiring the co-
ordination and collaboration of psychiatrists and
other mental health workers from different
theoretical backgrounds and from widely separa-
ted countries with different cultures and socio-
economic conditions. The second major con-
2lt is not possible to list all team members in this space.
Participating psychiatrists are listed in the footnote on page
422 but the project could not have been carried out without
the help of the other workers involved.
elusion is that it is possible to develop reliable
research instruments and procedures for practical
use in international psychiatric studies. The third
major conclusion is that similar groups of
schizophrenic patients can be identified in every
one of the nine countries involved in the study. In
addition, there are some groups of schizophrenic
patients which have centre-specific characteristics.
These findings are important, because it has
often been said that transcultural psychiatric
studies cannot be done effectively because
differences in diagnostic practice are irrecon-
cilable. What is striking about the IPSS ex-
perience is that, with a relatively small amount of
training, psychiatrists from nine countries were
able to look at patients in a standardized manner
for research purposes and find groups of schizo-
phrenics similar in many respects in all of their
countries.
Another implication of the IPSS findings
relates to the fact that, in the past, it has been
very difficult to compare the results of one study
of schizophrenia with another because it has
rarely been clear whether the same entity has
been studied in both cases. This problem has
limited the usefulness of biochemical, genetic,
psychopharmacological, sociocultural, and other
studies of schizophrenia. The methodology of
the IPSS provides a reliable way for identifying
and describing similar groups of schizophrenic
patients, so that they can be studied in a variety
of ways by different investigators in various
countries with the reasonable assurance that the
same entity is being studied.
A parallel benefit from such a pilot study has
been the development of a network of research
centres in various countries, which can serve as
solid bases for future international work. Train-
ing of a number of psychiatrists and other mental
health workers in the field of epidemiological and
social psychiatry has been a concurrent and
valuable activity. In the future, expansion of
such training will be implemented in accordance
with the objectives of Programme D.
The field research centre was the basic unit of
implementation of the study. Factors that went
into the selection of a field research centre
included the availability of a well-trained
psychiatrist with knowledge and experience in
epidemiological research, the presence of other
tiained psychiatrists and supporting staff, and
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the existence of a network of services that would
detect likely and early cases of schizophrenia
occurring in a population of approximately half
a million to one million people. Other criteria
provided that the population of the catchment
area of the centre should be as little mobile as
possible and be socioculturally heterogeneous.
In addition, census data had to be available, and
the field research centre was to be strategically
located in relation to its continuing academic and
administrative influence on the future mental
health services in its country. WHO Head-
quarters in Geneva was made the central
organizing headquarters for the study, since it
was well suited to handling the administrative
problems of coordinating research activities and
data analyses.
All patients contacting the treatment facility
at a field research centre were screened for
inclusion in the study on the basis of demo-
graphic and symptomatic criteria. Patients were
included in the study who were 15 to 44 years of
age, had resided in the catchment area for at least
six months before inclusion, had no evidence of
organic psychiatric disease, and showed at least
one of a number of specific symptoms. One
thousand, two hundred and two patients who
satisfied these criteria received an intensive
initial evaluation by the research team at the field
research centre. Patients seen in initial evaluation
are being re-evaluated at one and two year
follow-up periods. The initial evaluation of a
patient lasted up to five hours and resulted in the
accumulation of some 1,600 items of information.
In order to obtain this information in a
standardized manner, it was necessary to develop
a standardized set of research instruments. Eight
instruments were used in the study, of which the
three basic instruments were the Present State
Examination (PSE), the Psychiatric History
schedule (PH), and the Social Description
schedule (SD).
The Present State Examination is a guide to
structuring a clinical interview which has been
developed over the past 10 years by Professor J.
Wing and co-workers at the Social Psychiatry
Research Unit, Medical Research Council, in
London. It was specially modified to make it
applicable in all of the vastly different socio-
cultural conditions in which this study took
place. Although it provides for a structured
interview, it can be administered in a flexible,
clinical manner, according to the clinical style of
the interviewer and the necessities of the clinical
situation. Basically, this schedule is a list of items
to be observed and asked about which systemati-
cally covers all of the phenomena likely to be
considered during a comprehensive examination
of a patient's current mental condition.
The Psychiatric History and Social Descrip-
tion schedules were developed during the course
of the study by headquarters staff, the collaborat-
ing investigators, and consultants. They evolved
gradually, after many tests under field conditions.
As one of the major aims of the IPSS was to
determine if standardized instruments for evalua-
tion of patients could be developed, an important
part of the study was the analysis of the reliability
of the data collected through the use of these
instruments, particularly the PSE.
Two methods were used to evaluate the
reliability of the PSE. In order to test intra-
centre reliability, every sixth patient was assessed
by two psychiatrists simultaneously. Each
psychiatrist independently rated the patient, and
his ratings were compared with those of the other
psychiatrist. A total of 189 of these interviews
was performed. To assess inter-centre reliability,
21 interviews, live or from videotapes and films,
were each simultaneously rated by psychiatrists
from various centres.
Reliability investigations based on this data
indicate that it was possible to obtain satisfactory
reliability among interviewers. Intra-centre re-
liability was higher than inter-centre reliability,
and ratings made on the basis of patients'
reports were more reliable than those made from
observation of behaviour.
As the full set of research instruments yields
over 2,000,000 items of information for the 1,202
patients in the study, special methods had to be
developed to handle and analyse such massive
amounts of data effectively.
Using these methods it was, for example,
possible to construct profiles of symptomatology
for each patient and each group of patients. The
profiles of various groups of patients can then be
compared. The Figure illustrates how such
profiles can be used to compare a group of
schizophrenic patients with a group of psychoti-
cally depressed patients.
The data accumulated in the study has been
available at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291700045244
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 10:09:39, subject to the Cambridge Core terms of use,
WHO International Pilot Study of Schizophrenia—Preliminary Communication 425
100
80
S 60
| "0
20
schizophrenic group
" " " (ICD categories 296.0-295.9), 811 pts
psvchotic depression group
" " " ( ICD categories 296.0, 296.2, 298.0), 78 pts.
3 4 5 6 7 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
thinking perception affect other behaviour operation
MAJOR AREAS OF DYSFUNCTION
FIGURE IPSS initial examination: average scores of patients with schizophrenia and patients with psychotic depression.
analysed in a variety of ways, and it is not pos-
sible to present all the results in this space.
Analyses were carried out at WHO Head-
quarters and some centres also participated in
data analysis. For example, the London centre
has developed a computer diagnostic programme
to classify patients on the basis of information
compiled from the PSE and Psychiatric History
schedules. The Washington centre has done
cluster analysis on the data about the patients in
the study, to determine what groups of patients
are formed when equal weight is given to all data
and the classification is done by mathematical
analysis. Other centres are developing special
studies aimed at elucidation of problems
identified during the course of the main study.
The results of these analyses will be presented in
detail in Volume I of the report of the IPSS,
which is expected to be published during the
course of this year.
The field research centres are now in the pro-
cess of completing a two year follow-up of the
patients in the study. Thus far, information has
been obtained about more than 80 % of patients
who received an initial evaluation. Data analysis
on the follow-up information is proceeding at
headquarters in WHO.
From the data already analysed in the initial
portion of the study, it can be concluded that it
is possible to identify groups of schizophrenic
patients with similar symptomatology in each of
the IPSS centres. This is a finding of major
importance for further studies and research in
psychiatry. Reliable, large-scale international
psychiatric studies have been shown to be feasible
and it has been demonstrated that internationally
applicable research instruments and procedures
can be developed. An international network of
centres has been established which can serve as a
nucleus for further research and training in
epidemiological and social psychiatry. Scientific
groundwork has thus been laid for a psychiatric
epidemiology which can serve psychiatry as
medical epidemiology serves general medicine.
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